Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia
- PMID: 16789835
- PMCID: PMC1475659
- DOI: 10.1371/journal.ppat.0020053
Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia
Abstract
Influenza A virus (IAV) is the etiological agent of a highly contagious acute respiratory disease that causes epidemics and considerable mortality annually. Recently, we demonstrated, using an in vitro approach, that the pattern recognition Toll-like receptor (TLR)3 plays a key role in the immune response of lung epithelial cells to IAV. In view of these data and the fact that the functional role of TLR3 in vivo is still debated, we designed an investigation to better understand the role of TLR3 in the mechanisms of IAV pathogenesis and host immune response using an experimental murine model. The time-course of several dynamic parameters, including animal survival, respiratory suffering, viral clearance, leukocyte recruitment into the airspaces and secretion of critical inflammatory mediators, was compared in infected wild-type and TLR3(-/-) mice. First, we found that the pulmonary expression of TLR3 is constitutive and markedly upregulated following influenza infection in control mice. Notably, when compared to wild-type mice, infected TLR3-/- animals displayed significantly reduced inflammatory mediators, including RANTES (regulated upon activation, normal T cell expressed and secreted), interleukin-6, and interleukin-12p40/p70 as well as a lower number of CD8+ T lymphocytes in the bronchoalveolar airspace. More important, despite a higher viral production in the lungs, mice deficient in TLR3 had an unexpected survival advantage. Hence, to our knowledge, our findings show for the first time that TLR3-IAV interaction critically contributes to the debilitating effects of a detrimental host inflammatory response.
Conflict of interest statement
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1483229/bin/ppat.0020053.g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1483229/bin/ppat.0020053.g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1483229/bin/ppat.0020053.g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1483229/bin/ppat.0020053.g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1483229/bin/ppat.0020053.g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/1483229/bin/ppat.0020053.g006.gif)
Similar articles
-
Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.J Immunol. 2011 May 15;186(10):5590-602. doi: 10.4049/jimmunol.1002348. Epub 2011 Apr 13. J Immunol. 2011. PMID: 21490153
-
Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway.J Immunol. 2009 Jun 15;182(12):7795-802. doi: 10.4049/jimmunol.0803743. J Immunol. 2009. PMID: 19494303
-
Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential.Biol Chem. 2004 Nov;385(11):1029-34. doi: 10.1515/BC.2004.133. Biol Chem. 2004. PMID: 15576322 Review.
-
Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.J Leukoc Biol. 2004 Oct;76(4):886-95. doi: 10.1189/jlb.1203644. Epub 2004 Jul 7. J Leukoc Biol. 2004. PMID: 15240757
-
[The thioldisulfide system as one of the elements of compensatory mechanisms in influenza].Vestn Akad Med Nauk SSSR. 1991;(4):40-4. Vestn Akad Med Nauk SSSR. 1991. PMID: 1866986 Review. Russian.
Cited by
-
Defining the balance between optimal immunity and immunopathology in influenza virus infection.Nat Rev Immunol. 2024 May 2. doi: 10.1038/s41577-024-01029-1. Online ahead of print. Nat Rev Immunol. 2024. PMID: 38698083 Review.
-
TRIF-dependent signaling and its role in liver diseases.Front Cell Dev Biol. 2024 Apr 17;12:1370042. doi: 10.3389/fcell.2024.1370042. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38694821 Free PMC article. Review.
-
SP-R210 isoforms of Myosin18A modulate endosomal sorting and recognition of influenza A virus infection in macrophages.Microbes Infect. 2024 Mar-Apr;26(3):105280. doi: 10.1016/j.micinf.2023.105280. Epub 2023 Dec 21. Microbes Infect. 2024. PMID: 38135024
-
Sodium-Glucose Cotransporter-2 Inhibitor, Empagliflozin, Suppresses the Inflammatory Immune Response to Influenza Infection.Immunohorizons. 2023 Dec 1;7(12):861-871. doi: 10.4049/immunohorizons.2300077. Immunohorizons. 2023. PMID: 38112660 Free PMC article.
-
Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment.J Cancer Metastasis Treat. 2023;9:10. doi: 10.20517/2394-4722.2022.92. Epub 2023 Apr 4. J Cancer Metastasis Treat. 2023. PMID: 37974615 Free PMC article.
References
-
- Wright PF, Webster R. Orthomyxoviruses. In: Knipe DM, Howley PM, editors. Fields virology, 4th edition. Philadelphia: Lippincott-Raven; 2001. pp. 1533–1579.
-
- Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: A mechanism for the unusual severity of human disease? Lancet. 2002;360:1831–1837. - PubMed
-
- Kandel R, Hartshorn KL. Novel strategies for prevention and treatment of influenza. Expert Opin Ther Targets. 2005;9:1–22. - PubMed
-
- Palese P. Influenza: Old and new threats. Nat Med. 2004;10:S82–S87. - PubMed
-
- Hayden FG. Pandemic influenza: Is an antiviral response realistic? Pediatr Infect Dis J. 2004;23:S262–S269. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials